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Edited by Peter BrzezinskiAbstract We investigated the antimicrobial eﬀects of Ure-
chistachykinins I and II (UI and UII) and their modes of action.
UI and UII showed antimicrobial activities without a hemolytic
eﬀect. To investigate the mechanism(s) of UI and UII, cellular
localization was examined. Confocal microscopy results showed
that peptides were located in the cell envelope. To elucidate the
physical changes of membrane induced by UI and UII in Can-
dida albicans, ﬂow cytometry analyses were performed by using
bis-(1,3-dibutylbarbituric acid) trimethine oxonol, and changes
in membrane dynamics were assessed using 1,6-diphenyl-1,3,5-
hexatriene. The results suggest that UI and UII may exert their
antimicrobial eﬀect by disrupting the cell membranes.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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unicinctus1. Introduction
Short cationic amphipathic peptides with antimicrobial
activities and/or immunomodulatory activities (antimicrobial
peptides) are present in virtually every life form as an impor-
tant component of innate immune defenses [1,2]. Similarly to
antimicrobial peptides, peptides with neural or neuroendocrine
signaling functions (neuropeptides) are generally amphipathic
molecules, a property that permits them to achieve high local
concentrations in the aqueous space between the nerve ending
and receptor, as well as the target membrane. This shared
property of amphipathicity led to the discovery of antimicro-
bial activities of many neuropeptides, and some have been
shown to have potent antimicrobial activity [3,4]. In Caeno-
rhabditis elegans, a conserved family of infection-induced, neu-
ropeptide-like proteins (NLP-27, NLP-28, NLP-29, NLP-30,
NLP-31, NLP-33) were found and thought to have neuromod-Abbreviations: UI, Urechistachykinin I; UII, Urechistachykinin II;
DMSO, dimethyl sulfoxide; MTT, (3-(4,5-Dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide); CLSM, confocal laser scanning
microscopy; DiBAC4(3), bis-(1,3-dibutylbarbituric acid) trimethine
oxonol; PBS, phosphate buﬀered saline; DPH, 1,6-diphenyl-1,3,5-
hexatriene
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vous system, substance P, involved in pain, signal
transmission, inﬂammatory processes and vasodilatation, has
an antimicrobial activity [3,6].
If a long list of neuropeptides is examined it is possible to
formulate several groups based on the sequence homologies
of amino acids that constitute the neuropeptides. One of these
groups is the tachykinin superfamily [7]. Some peptides of the
tachykinin superfamily, including substance P, contain the
consensus sequence – Phe-X-Gly-Leu-Met-NH2 at their C-ter-
mini [8]. Peptides with some sequence similarities to that of the
tachykinin superfamily have also been identiﬁed from inverte-
brates. These peptides have been designated tachykinin-related
peptides (TRPs) and are characterized by the preserved C-ter-
minal pentapeptide – Phe-X-Gly-Y-Arg-NH2 (X and Y are
variable residues) [9]. UI and UII are examples of TRPs. They
were isolated from the ventral nerve cords of the echiuroid
worm, Urechis unicinctus. These peptides showed a contractile
action on the inner circular body-wall muscle of the animal
[10]. Similar properties of UI and UII to substance P – they
are neuropeptides that have sequence similarities. This leads
us to think that UI and UII might have similar antimicrobial
activities like substance P.
In this study, antimicrobial activities of UI and UII were
measured. We then investigated the antimicrobial mechanism
of the UI and UII and suggested a potential for providing a
template regarding the design of a potent antimicrobial peptide
possessing a novel antimicrobial mechanism.2. Materials and methods
2.1. Materials
Vancomycin, kanamycin and amphotericin B were purchased from
the Sigma Chemical Co. (St. Louis, Mo, USA). Stock solutions of van-
comycin and kanamycin were prepared in sterile distilled water and
solutions of amphotericn B were prepared in dimethyl sulfoxide
(DMSO) and stored at 20 C. For all experiments, a ﬁnal concentra-
tion of 1% DMSO was used as the solvent carrier.2.2. Peptide synthesis
The peptides were synthesized by the solid phase method using 9-ﬂu-
orenyl-methoxycarbonyl chemistry [11]. The crude peptide was repeat-
edly washed with diethylether, dried in a vacuum, and puriﬁed using a
reversed-phase preparative HPLC on a Waters 15-lm Deltapak C18
column (19 · 30 cm). The purity of the peptide was checked by an ana-
lytical reversed-phase HPLC on an Ultrasphere C18 column
(4.6 · 25 cm; Beckman, Fullerton, CA, USA). The molecular weights
of the synthetic peptides were determined using a matrix-assisted laser
desorption ionization MALDI-mass spectrometer [12].ation of European Biochemical Societies.
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Streptococcus mutans (KCTC 3065), Trichosporon beigelii (KCTC
7707) and Malassezia furfur (KCTC 7744) were obtained from the
Korean Collection for Type Cultures (KCTC) of the Korea Research
Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Staphylococcus aureus (ATCC 25923), Enterococcus faecium (ATCC
29212), Escherichia coli O-157 (ATCC 43895), Pseudomonas aeruginosa
(ATCC 27853), Vibrio vulniﬁcus (ATCC 29307) and Candida albicans
(ATCC 90028) were obtained from the American Type Culture Collec-
tion (ATCC) (Manassas, VA, USA). Bacterial cells were cultured in a
Mueller-Hinton broth (Difco, Sparks, MD, USA) with aeration at
37 C. Fungal cells were cultured in a YPD broth (Difco) with aeration
at 28 C. M. furfur was cultured at 32 C in a modiﬁed Bacto yeast ex-
tract/ malt extract (YM) broth (Difco) and 1% olive oil.
2.4. Determining of antimicrobial susceptibility
Bacterial cells (2 · 107/ml), inoculated into a Mueller-Hinton broth
and 0.1 ml/well, were dispensed in 96-well microtiter plates. MICs were
determined by means of a serial 2-fold dilution of test peptides in fol-
lowing the recommendations of the Clinical and Laboratory Standards
Institute (CLSI) [13]. After 24 h of incubation at 37 C, the minimal
concentration of peptide to prevent the growth of a given test organism
was determined and deﬁned as MIC. Growth was assayed with a
microtiter ELISA Reader (Molecular Devices Emax, CA, USA) by
monitoring absorption at 620 nm. Fungal cells (2 · 104/ml) were inoc-
ulated into an YPD or YM broth and 0.1 ml/well were dispensed into
microtiter plates. MICs were determined by a serial 2-fold dilution of
test peptides, following a micro-dilution method and MTT (3-(4,5-di-
methyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay [14].
After 48 h of incubation at either 28 C or 32 C, the minimal concen-
tration of peptide to prevent the growth of a given test organism was
determined and deﬁned as MIC. Growth was assayed with a microtiter
ELISA Reader by monitoring absorption at 580 nm. MIC values were
determined by three independent assays.2.5. Hemolytic activity against human erythrocytes
The hemolytic activity of the peptides was evaluated by determining
the release of hemoglobin from a 4% suspension of fresh human
erythrocytes at 414 nm with an ELISA plate Reader [14]. The hemoly-
sis percentage was calculated by using the following equation: Percent-
age hemolysis = [(Abs414 nm in the peptide solution  Abs414 nm in
a PBS)/ (Abs414 nm in 0.1% Triton X-100  Abs414 nm in a PBS)] · 100.
2.6. Confocal laser scanning microscopy (CLSM)
The intracellular distribution of peptides was analyzed by means of a
CLSM. Cells were treated with FITC-labeled UI or UII and incubated
for 5 min at 28 C. After incubation, cells were harvested by centrifu-
gation at 10000 rpm for 5 min and washed with an ice-cold phosphate
buﬀered saline (PBS [pH 7.4]). Visualization and localization of the la-
beled peptide were performed by a Laser Scanning Spectral Confocal
Microscope (Leica TCS SP2, Leica, Swiss).
2.7. Flow cytometric analysis for the plasma membrane potential
For analysis of the membrane integrity after peptide treatment, log-
phased cells of C. albicans (1 · 108 cells) were harvested and resus-
pended with a 1-ml fresh YPD medium, containing UI, UII or melit-
tin (at the MIC) as a positive control. After incubation for 3 h, the
cells were washed with a PBS. To detect depolarization of the cell
membrane, 1 ml PBS containing 50 lg of bis-(1,3-dibutylbarbituric
acid) trimethine oxonol (DiBAC4(3); Molecular Probes, Eugene,
OR, USA), was added and the samples were incubated for 1 h at
4 C in the dark [15]. Flow cytometric analysis was performed via a
FACSCalibur ﬂow cytometer (Becton Dickinson, San Jose, CA,
USA).Table 1
Amino acid sequences and molecular masses determined by MALDI-
MS of Urechistachykinins
Peptides Amino acid sequences Calculated
values
Observed
values
Retention
time (min)
UI LRQSQFVGSR-NH2 1176.3 1176.7 12.220
UII AAGMGFFGAR-NH2 983.1 982.9 15.8422.8. Measurement of plasma membrane ﬂuorescence anisotropy
Fluorescence from the plasma membrane of C. albicans cells labeled
with 1,6-diphenyl-1,3,5-hexatriene (DPH; Molecular Probes) were de-
tected to investigate changes in membrane dynamics. Fungal cells
(1 · 108 cells) were treated with peptides in the concentration range
between 0 and MIC values and incubated for 3 h at 28 C. Labeling
and ﬂuorescence measurement were performed, exactly as described
[16].3. Results and discussion
Peptides were chemically synthesized by the solid phase
method, and were identiﬁed by amino acid analysis and MAL-
DI-mass spectroscopic analysis (Table 1). In this study, melittin
(GIGAVLKVLTTGLPALISWIKRKRQQ-NH2), a 26-resi-
due peptide which is derived from the venom of the European
honey bee Apismellifera, was used as reference to compare with
UI and UII. Melittin is an antimicrobial peptide with a power-
ful lytic activity against both bacterial and eukaryotic cells [17].
Additionally, vancomycin, kanamycin and amphotericin B
were used as positive controls against Gram-positive bacteria,
Gram-negative bacteria and fungi, respectively.
The antibacterial activities of UI and UII against human
pathogenic Gram-positive and Gram-negative species of bacte-
ria were determined by using the broth micro-dilution method.
The antibacterial activity of UII was stronger than that of UI.
However, the antibacterial activities of UI and UII are less po-
tent compared to melittin. Although UI and UII were less ac-
tive than vancomycin against Gram-positive bacteria, these
peptides exhibited 4–8-fold increased activity compared to
kanamycin against Gram-negative bacteria. The bacterial
strains tested are susceptible to UI and UII with MIC values
in the 10.6–42.5 lM range, while melittin is determined at
the MIC value of 1.1–4.4 lM (Table 2). The antifungal activ-
ities of UI and UII were measured by MTT assay. UI showed
strong activity at levels of 21.3–42.5 lM. The fungal strains
tested are susceptible to UII with MIC values in the 12.7–
50.9 lM range. The antifungal activities of UI and UII are less
potent than that of melittin, which is determined at the MIC
value of 4.4–8.8 lM. However, UI and UII displayed similar
antifungal activities compared to amphotericin B which is
determined at the MIC value of 3.4–54 lM (Table 2).
Although most antimicrobial peptides exhibited relatively
good cell selectivity, between microbial cells versus mamma-
lian host cells, some antimicrobial peptides show a lytic activ-
ity toward mammalian cells. Therefore, we examined the
ability of UI and UII in causing the hemolysis of human eryth-
rocytes as a measure of their toxicity to mammalian cells. UI
and UII showed no cytotoxicity on human erythrocytes at
all tested concentrations, while melittin exhibited a potent
hemolytic activity regarding most tested concentration
amounts (Table 3). These results demonstrated that UI and
UII have high selectivity of antimicrobial activities; in other
words, these peptides possess cell selectivity between microbial
cells and mammalian cells.
To provide information on the mode of antimicrobial action
of UI and UII, we have selected C. albicans as a model organ-
ism, which is both a commensal and opportunistic pathogen of
ever-increasing medical importance [18]. To examine the target
sites of UI and UII in C. albicans, these were labeled with
FITC and visualized under confocal microscopy. FITC-la-
beled UI and UII accumulated in the cell envelope immedi-
Table 2
Antimicrobial activities of UI and UII
Microorganisms MIC (lM)
UI UII Vancomycin Kanamycin Amphotericin B Melittin
Gram-positive bacteria
Streptococcus mutans 21.3 12.7 4.2 ND ND 1.1
Staphylococcus aureus 42.5 25.4 4.2 ND ND 4.4
Enterococcus faecium 21.3 25.4 8.4 ND ND 2.2
Gram-negative bacteria
Escherichia coli O-157 10.6 12.7 NDa 10.7 ND 1.1
Pseudomonas aeruginosa 21.3 12.7 ND 172 ND 2.2
Vibrio vulniﬁcus 42.5 25.4 ND 172 ND 4.4
Fungi
Candida albicans 42.5 25.4 ND ND 27 8.8
Trichosporon beigelii 21.3 12.7 ND ND 54 4.4
Malassezia furfur 42.5 50.9 ND ND 3.4 8.8
aND, Not done.
Table 3
Hemolytic activities of the peptides against human erythrocyte cells
Peptides % Hemolysis (lM)
100 50 25 12.5 6.25 3.12
UI 0 0 0 0 0 0
UII 0 0 0 0 0 0
Melittin 100 100 100 100 100 75
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jor target site of UI and UII is the envelope of the fungal cells.Fig. 1. Confocal ﬂuorescence microscopy of Candida albicans cells treated wit
Fig. 2. FACScan analysis of DiBAC4(3) staining in Candida albicans. Histog
albicans were treated with peptides.To assess whether UI and UII aﬀect the function of the fun-
gal plasma membrane, we investigated their ability to dissipate
the membrane potential of C. albicans. C. albicans cells were
cultured in the presence or absence of UI, UII or melittin and
the amounts of accumulated DiBAC4(3) in cells with ﬂow
cytometry by staining with DiBAC4(3) were measured.
DiBAC4(3) has a high voltage sensitivity and can enter depolar-
ized cells, where it binds to lipid-rich intracellular components
[15]. As shown in Fig. 2, similarly to melittin, which is known
as a membrane-acting antimicrobial peptide, UI or UII-treated
cells caused a higher accumulation of DiBAC4(3) than peptide-h FITC-labeled peptides: (A) treated with UI and (B) treated with UII.
rams showed the ﬂuorescence intensity of stained DiBAC4(3) after C.
Fig. 3. DPH ﬂuorescence anisotropy after the addition of peptides.
Treatment with UI, UII, or melittin in the concentration range
between 0 and MIC values, and the error bars represent the standard
deviation (SD) values for three independent experiments, performed in
triplicate.
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yeast cells by injuring their membranes, thus disrupting mem-
brane potential.
The eﬀects of UI and UII on the fungal plasma membrane
were further investigated with a ﬂuorescent membrane probe.
DPH is a hydrophobic molecule and this property makes it
possible to associate with the hydrocarbon tail region of phos-
pholipids within the cytoplasmic membrane without disturbing
the structure of the lipid bilayer [19]. Assuming the antifungal
activities by UI and UII on C. albicans are exerted at the level
of the plasma membrane, DPH, which interacts with an acyl
group of the plasma membrane lipid bilayer, would not be in-
serted into the membrane. The results showed that the DPH
ﬂuorescence anisotropy of UI or UII-treated cells decreased
in a dose-dependent manner, but less so than in regards to
the decrease of ﬂuorescence anisotropy in the presence of mel-
ittin (Fig. 3). This suggested that the plasma membrane is
structurally disrupted when exposed to UI or UII. As for the
mechanism by which they break down the membrane perme-
ability barrier, it is possible that UI and UII perturb the mem-
brane lipid bilayers, causing the dissipation of the electrical
potential of the membrane. Although the exact mechanism
of the actions of UI and UII has not as yet been fully eluci-
dated, the results reported here indicate their eﬀects on the
plasma membrane. Therefore, it is concluded that UI and
UII have considerable antimicrobial activity, thus further
investigation for clinical applications is required.
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